Literature DB >> 10588934

Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.

M Connor1, C W Vaughan, E A Jennings, R G Allen, M J Christie.   

Abstract

1. The actions of the neuropeptide nociceptin, the putative nociceptin receptor antagonist [Phe1psi(CH(2)-NH)Gly(2)]-nociceptin-(1 - 13)NH(2) (Phe(1)psi-nociceptin(1 - 13)) and the putative nociceptin precursor products nocistatin (rat prepronociceptin(125 - 132)) and rat prepronociceptin(154 - 181) were examined on membrane properties of rat locus coeruleus (LC) neurons using whole cell patch clamp techniques. 2. Nociceptin inhibited I(Ba) in all LC neurons, (pD(2) of 8.9, maximum inhibition 50%). The inhibition of I(Ba) by nociceptin was associated with slowing of the activation of I(Ba) and could be significantly reversed by a strong depolarizing prepulse. Phe(1)psi-nociceptin(1 - 13) also inhibited I(Ba) in LC neurons (notional pD(2) of 7.6, maximum inhibition 18%). Application of Phe(1)psi-nociceptin(1 - 13) (1 microM) significantly occluded the subsequent effects of a co-application of nociceptin (3 nM) on I(Ba). 3. As previously reported for nociceptin, Phe(1)psi-nociceptin(1 - 13) caused an outward current in LC neurons voltage clamped at -60 mV (pD(2) of 7.1, maximum current 50% of that of methionine enkephalin, 10 microM). The Phe(1)psi-nociceptin(1 - 13) induced current reversed polarity at -112 mV and exhibited pronounced inward rectification. Phe(1)psi-nociceptin(1 - 13) (1 microM) reversibly inhibited the current caused by nociceptin (300 nM) by 30%. 4. Neither nocistatin nor rat prepronociceptin(154 - 181) inhibited I(Ba) in LC neurons, or prevented the subsequent inhibition by nociceptin. Neither nocistatin or prepronociceptin(154 - 181) affected the membrane properties of LC neurons. 5. This study demonstrates that nociceptin modulates somatic I(Ba) in rat LC neurons. The putative ORL1 antagonist Phe(1)psi-nociceptin(1 - 13) exhibited partial agonist activity at inhibiting I(Ba) and opening K(+) channels in LC. Other putative nociceptin precursor products were without effect on LC cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588934      PMCID: PMC1571808          DOI: 10.1038/sj.bjp.0702971

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits.

Authors:  S R Ikeda
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

2.  cDNA cloning of an orphan opiate receptor gene family member and its splice variant.

Authors:  J B Wang; P S Johnson; Y Imai; A M Persico; B A Ozenberger; C M Eppler; G R Uhl
Journal:  FEBS Lett       Date:  1994-07-04       Impact factor: 4.124

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  The locus coeruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat.

Authors:  L W Swanson
Journal:  Brain Res       Date:  1976-06-25       Impact factor: 3.252

5.  Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.

Authors:  J U Adams; C A Paronis; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

6.  Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.

Authors:  E Mjanger; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1991-08       Impact factor: 4.030

7.  Rat vas deferens: a specific bioassay for endogenous opioid peptides.

Authors:  S Lemaire; J Magnan; D Regoli
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

8.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

9.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

View more
  9 in total

1.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala.

Authors:  S Meis; H C Pape
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

3.  Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats.

Authors:  D Albrecht; R Blühdorn; H Siegmund; H Berger; G Calo'
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

4.  Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.

Authors:  C W Vaughan; M Connor; E A Jennings; S Marinelli; R G Allen; M J Christie
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

5.  Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain.

Authors:  V Laudenbach; G Calo; R Guerrini; G Lamboley; J F Benoist; P Evrard; P Gressens
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 6.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

Review 7.  Synaptic effects induced by alcohol.

Authors:  David M Lovinger; Marisa Roberto
Journal:  Curr Top Behav Neurosci       Date:  2013

8.  Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Authors:  M Fantin; C Fischetti; C Trapella; M Morari
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

9.  Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.

Authors:  Matteo Marti; Sara Stocchi; Francesca Paganini; Flora Mela; Carmela De Risi; Girolamo Calo'; Remo Guerrini; Timothy A Barnes; David G Lambert; Lorenzo Beani; Clementina Bianchi; Michele Morari
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.